Skip to main content

Animations

MJFF Publications

3461 - 3470 of 6295 Results
Title
Year
  • Year
  • 2019
  • 2016
  • 2024
  • 2018
  • 2024
  • 2020
  • 2016
  • 2021
  • 2020
  • 2020
  • Summary Details
    OPEN
    Title: Increased Dynamics of α-Synuclein Fibrils by β-Synuclein Leads to Reduced Seeding and Cytotoxicity
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41598-019-54063-8
    Citation Count: 25
  • Summary Details
    OPEN
    Title: Development of Chemical Probes for Investigation of Salt-Inducible Kinase Function in Vivo
    Journal Name: ACS Chemical Biology
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1021/acschembio.6b00217
    Citation Count: 73
  • Summary Details
    OPEN
    Title: A simulated annealing algorithm for randomizing weighted networks
    Journal Name: Nature Computational Science
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s43588-024-00735-z
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Deep gray matter volume loss drives disability worsening in multiple sclerosis
    Journal Name: Annals of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/ana.25145
    Citation Count: 392
  • Summary Details
    OPEN
    Title: Comprehensive real time remote monitoring for Parkinson’s disease using Quantitative DigitoGraphy
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-024-00751-w
    Citation Count: 5
  • Summary Details
    OPEN
    Title: LRRK2 inhibitors induce reversible changes in nonhuman primate lungs without measurable pulmonary deficits
    Journal Name: Science Translational Medicine
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1126/scitranslmed.aav0820
    Best OA location URL:
    Citation Count: 114
  • Summary Details
    OPEN
    Title: JUMPg: An Integrative Proteogenomics Pipeline Identifying Unannotated Proteins in Human Brain and Cancer Cells
    Journal Name: Journal of Proteome Research
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1021/acs.jproteome.6b00344
    Citation Count: 84
  • Summary Details
    OPEN
    Title: Protein Profiling of RGS6, a Pleiotropic Gene Implicated in Numerous Neuropsychiatric Disorders, Reveals Multi-Isoformic Expression and a Novel Brain-Specific Isoform
    Journal Name: eneuro
    Publisher: Society for Neuroscience
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1523/eneuro.0379-21.2021
    Citation Count: 10
  • Summary Details
    OPEN
    Title: Cortical disinhibition in Parkinson’s disease
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/brain/awaa274
    Citation Count: 68
  • Summary Details
    OPEN
    Title: Human Peripheral Blood Neutrophil Isolation for Interrogating the Parkinson's Associated LRRK2 Kinase Pathway by Assessing Rab10 Phosphorylation
    Journal Name: Journal of Visualized Experiments
    Publisher: MyJove Corporation
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.3791/58956-v
    Citation Count: 6
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.